Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Environ Toxicol ; 39(7): 4058-4065, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38661261

RESUMO

Platinum-based antineoplastic drugs, including cisplatin, carboplatin, and oxaliplatin, are widely used in the treatment of various cancers. Ototoxicity is a common adverse effect of platinum-based drugs. Ototoxicity leads to irreversible hearing impairment. We hypothesize that different platinum-based drugs exhibit varying ototoxic concentrations, time effects, and ototoxic mechanisms. We tested this hypothesis by using a zebrafish model (pvalb3b: TagGFP) to assess the viability of hair cells collected from zebrafish larvae. Cisplatin, carboplatin, and oxaliplatin were administered at dosages of 100, 200, or 400 µM, and the ototoxic effects of these drugs were assessed 1, 2, or 3 h after administration. Fm4-64 and a TUNEL assay were used to label the membranes of living hair cells and to detect cell apoptosis, respectively. We observed that >50% of hair cells were damaged at 1 h after cisplatin (100 µM) exposure, and this ototoxic effect increased at higher dosages and over time. Owing to the smaller ototoxic effects of carboplatin and oxaliplatin, we conducted higher-strength and longer-duration experiments with these drugs. Neither carboplatin nor oxaliplatin was obviously ototoxic, even at 1600 µM and after 6 h. Moreover, only cisplatin damaged the membranes of the hair cells. Cell apoptosis and significantly increased antioxidant gene expression were observed in only the cisplatin group. In conclusion, cisplatin significantly damages sensory hair cells and has notable dosage and time effects. Carboplatin and oxaliplatin are less ototoxic than cisplatin, likely due to having different ototoxic mechanisms than cisplatin.


Assuntos
Antineoplásicos , Apoptose , Carboplatina , Cisplatino , Ototoxicidade , Oxaliplatina , Peixe-Zebra , Animais , Cisplatino/toxicidade , Oxaliplatina/toxicidade , Carboplatina/toxicidade , Antineoplásicos/toxicidade , Apoptose/efeitos dos fármacos , Células Ciliadas Auditivas/efeitos dos fármacos , Larva/efeitos dos fármacos
2.
Zhongguo Gu Shang ; 23(1): 46-8, 2010 Jan.
Artigo em Chinês | MEDLINE | ID: mdl-20191965

RESUMO

OBJECTIVE: To discuss the diagnosis and minimally invasive surgical treatment on severe acromioclavicular dislocation combined with coracoid process fracture. METHODS: Using 2 incisions of shoulder to expose and fix coracoid process and acromioclaricular joint and to repair damaged acromioclavicular ligament in 7 cases from March 1998 to March 2009. There was 2 males and 5 females in the patients. The age was from 23 to 57 years with an average of 44 yeas. The time from injury to operation was 3-7 d with an average of 4 days. According to Eyres typing, 2 cases were type 11 B, 5 cases were type III B. RESULTS: Seven patients were followed up from 6 months to 2 years with an average of 1 year. According to Karlsson criteria, 7 cases got grade A. CONCLUSION: Using 2 incisions of shoulder to expose and fix acromioclaricular joint and coracoid process with strong pertinence, reliable fixation and small tissue injury, which is a minimally invasive and effective method for severe acromioclavicular dislocation combined with coracoid process fracture.


Assuntos
Articulação Acromioclavicular/lesões , Articulação Acromioclavicular/cirurgia , Fraturas Ósseas/complicações , Fraturas Ósseas/cirurgia , Luxações Articulares/complicações , Luxações Articulares/cirurgia , Procedimentos Cirúrgicos Minimamente Invasivos , Adulto , Feminino , Seguimentos , Fraturas Ósseas/fisiopatologia , Fraturas Ósseas/terapia , Humanos , Luxações Articulares/fisiopatologia , Luxações Articulares/terapia , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa